Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
EBC-129 / A*Star, National Cancer Centre Singapore
EBC-129-01, NCT05701527: A Study of EBC-129 in Advanced Solid Tumours	Recruiting	1	84	US, RoW	EBC-129, Pembrolizumab	EDDC (Experimental Drug Development Centre), A*STAR Research Entities, Parexel	Advanced Solid Tumours	06/26	06/26